Department of Health (England) (2007) Drug misuse and dependence: UK guidelines on clinical management, London: Department of Health (England), the Scottish Government, Welsh Assembly Government and Northern Ireland ExecutiveRetrieved from www.nta.nhs.uk/uploads/clinical_guidelines_2007.pdf.
3.
Ford, C., & Law, F. (2014). Guidance for the use and reduction of misuse of benzodiazepines and other hypnotics and anxiolytics in general practice. Retrieved from www.smmgp.org.uk/download/guidance/guidance025.pdf.
Joint Formulary Committee. British national formulary. London, UK: BMJ Group and Pharmaceutical Press. Retrieved from http://www.medicinescomplete.com.
6.
LongoL. P.JohnsonB. (2000) Addiction: Part I. Benzodiazepines—side effects, abuse risk and alternatives. American Family Physician61(7): 2121–2128. Retrieved from www.aafp.org/afp/2000/0401/p2121.html.
7.
NHS Grampian. (2006). Guidance for prescribing and withdrawal of benzodiazepines and hypnotics in general practice. Retrieved from www.benzo.org.uk/amisc/bzgrampian.pdf.
8.
NICE. (2011). Clinical guideline 113: Generalised anxiety disorder and panic disorder (with or without agoraphobia) in adults: Management in primary, secondary and community care. Retrieved from www.nice.org.uk/Guidance/CG113.
9.
RickelsK.DowningR.SchweizerE.HassmanH. (1993) Antidepressants for the treatment of generalized anxiety disorder. A placebo-controlled comparison of imipramine, trazodene, and diazepam. Archives of General Psychiatry50(11): 884–895. doi: 10.1001/archpsyc.1993.01820230054005.